Major Pharmaceutical Conferences and Courses: August 2020 to September 2020.
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 3, p. 219, doi. 10.1007/s40290-020-00336-x
- Publication type:
- Article
Works matching IS 11782595 AND DT 2020 AND VI 34 AND IP 3
Results: 8
1
2
Sustainability in Inhaled Drug Delivery.
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 3, p. 191, doi. 10.1007/s40290-020-00339-8
- By:
- Publication type:
- Article
3
Career Planning for Physicians Within the Pharmaceutical Industry.
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 3, p. 175, doi. 10.1007/s40290-020-00338-9
- By:
- Publication type:
- Article
4
Forum.
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 3, p. 209, doi. 10.1007/s40290-020-00337-w
- Publication type:
- Article
5
Reliability and Validity of the M-MALMAS Instrument to Assess Medication Adherence in Malay-Speaking Patients with Type 2 Diabetes.
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 3, p. 201, doi. 10.1007/s40290-020-00335-y
- By:
- Publication type:
- Article
6
Optimal Use of the Non-Inferiority Trial Design.
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 3, p. 159, doi. 10.1007/s40290-020-00334-z
- By:
- Publication type:
- Article
7
Securitization of a Drug Development Mega-Fund: The Time-Certain Research-Backed Obligation.
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 3, p. 167, doi. 10.1007/s40290-020-00333-0
- By:
- Publication type:
- Article
8
Establishing Patient Registries for Rare Diseases: Rationale and Challenges.
- Published in:
- Pharmaceutical Medicine, 2020, v. 34, n. 3, p. 185, doi. 10.1007/s40290-020-00332-1
- By:
- Publication type:
- Article